115 related articles for article (PubMed ID: 2268688)
1. Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies.
Sitaram BR; McLeod WR
Biol Psychiatry; 1990 Nov; 28(10):841-8. PubMed ID: 2268688
[TBL] [Abstract][Full Text] [Related]
2. Gas chromatographic-mass spectroscopic characterisation of the psychotomimetic indolealkylamines and their in vivo metabolites.
Sitaram BR; Lockett L; McLeish M; Hayasaka Y; Blackman GL; McLeod WR
J Chromatogr; 1987 Nov; 422():13-23. PubMed ID: 3481368
[TBL] [Abstract][Full Text] [Related]
3. Study of metabolism of psychotomimetic indolealkylamines by rat tissue extracts using liquid chromatography.
Sitaram BR; Talomsin R; Blackman GL; McLeod WR
Biochem Pharmacol; 1987 May; 36(9):1503-8. PubMed ID: 3472525
[TBL] [Abstract][Full Text] [Related]
4. Indolealkylamines and prolactin secretion. A structure-activity study in the central nervous system of the rat.
Seeman G; Brown GM
Neuropharmacology; 1985 Dec; 24(12):1195-200. PubMed ID: 3867833
[TBL] [Abstract][Full Text] [Related]
5. Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC-APcI-MS-MS-isotope dilution method.
Barker SA; Littlefield-Chabaud MA; David C
J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(1):37-47. PubMed ID: 11232854
[TBL] [Abstract][Full Text] [Related]
6. Concise synthesis of N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine starting with bufotenine from Brazilian Anadenanthera ssp.
Moreira LA; Murta MM; Gatto CC; Fagg CW; dos Santos ML
Nat Prod Commun; 2015 Apr; 10(4):581-4. PubMed ID: 25973481
[TBL] [Abstract][Full Text] [Related]
7. In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat.
Sitaram BR; Lockett L; Talomsin R; Blackman GL; McLeod WR
Biochem Pharmacol; 1987 May; 36(9):1509-12. PubMed ID: 3472526
[TBL] [Abstract][Full Text] [Related]
8. 11C-labeling of indolealkylamine alkaloids and the comparative study of their tissue distributions.
Takahashi T; Takahashi K; Ido T; Yanai K; Iwata R; Ishiwata K; Nozoe S
Int J Appl Radiat Isot; 1985 Dec; 36(12):965-9. PubMed ID: 3866749
[TBL] [Abstract][Full Text] [Related]
9. Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues.
Kärkkäinen J; Forsström T; Tornaeus J; Wähälä K; Kiuru P; Honkanen A; Stenman UH; Turpeinen U; Hesso A
Scand J Clin Lab Invest; 2005; 65(3):189-99. PubMed ID: 16095048
[TBL] [Abstract][Full Text] [Related]
10. Cerebral and peripheral demethylation of psychotomimetics measured by expired 14CO2.
Sargent T; Braun U; Braun G; Kusubov N; Bristol KS
Int J Rad Appl Instrum B; 1989; 16(1):91-9. PubMed ID: 2497087
[TBL] [Abstract][Full Text] [Related]
11. A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.
Barker SA; McIlhenny EH; Strassman R
Drug Test Anal; 2012; 4(7-8):617-35. PubMed ID: 22371425
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat.
Sitaram BR; Lockett L; Blackman GL; McLeod WR
Biochem Pharmacol; 1987 Jul; 36(13):2235-7. PubMed ID: 3475068
[No Abstract] [Full Text] [Related]
13. The ion-pair extraction, purification, and liquid chromatographic analysis of indolealkylamines in human urine.
Sitaram BR; Blackman GL; McLeod WR; Vaughan GN
Anal Biochem; 1983 Jan; 128(1):11-20. PubMed ID: 6573860
[TBL] [Abstract][Full Text] [Related]
14. Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.
Shen HW; Wu C; Jiang XL; Yu AM
Biochem Pharmacol; 2010 Jul; 80(1):122-8. PubMed ID: 20206139
[TBL] [Abstract][Full Text] [Related]
15. Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations.
Corbett L; Christian ST; Morin RD; Benington F; Smythies JR
Br J Psychiatry; 1978 Feb; 132():139-44. PubMed ID: 272218
[TBL] [Abstract][Full Text] [Related]
16. The biosynthesis of 5-methoxy-N,N-dimethyltryptamine in vitro.
Mandel LR; Walker RW
Life Sci; 1974 Oct; 15(8):1457-63. PubMed ID: 4549987
[No Abstract] [Full Text] [Related]
17. Determination of N,N-dimethylindolealkylamines in plasma, blood and urine extracts by radioimmunoassay and high pressure liquid chromatography.
Riceberg LJ; Vunakis HV
J Pharmacol Exp Ther; 1978 Jul; 206(1):158-66. PubMed ID: 275476
[TBL] [Abstract][Full Text] [Related]
18. [Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders].
Matsumoto H; Pietruszewska I
Psychiatr Pol; 1978; 12(2):189-97. PubMed ID: 275869
[No Abstract] [Full Text] [Related]
19. [Extraction of serotonin, bufotenin, 5-methoxytryptamine and 5-methoxy-N,N-dimethyltryptamine and their fluorometric determination with o-phthaldialdehyde].
Kitzrow W; Franke L; Uebelhack R; Seidel K
Acta Biol Med Ger; 1980; 39(4):489-94. PubMed ID: 6934671
[TBL] [Abstract][Full Text] [Related]
20. Identification of N,N-dimethyltryptamine, 5-methoxy-N,N-dimethyltryptamine and bufotenin by cellulose TLC.
Baumann P; Narasimhachari
J Chromatogr; 1973 Nov; 86(1):269-73. PubMed ID: 4358118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
